2-227815559-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000358813.5(CCL20):āc.182A>Gā(p.Asn61Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000992 in 1,551,868 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000358813.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL20 | NM_004591.3 | c.182A>G | p.Asn61Ser | missense_variant | 2/4 | ENST00000358813.5 | NP_004582.1 | |
CCL20 | NM_001130046.2 | c.179A>G | p.Asn60Ser | missense_variant | 2/4 | NP_001123518.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL20 | ENST00000358813.5 | c.182A>G | p.Asn61Ser | missense_variant | 2/4 | 1 | NM_004591.3 | ENSP00000351671 | P4 | |
CCL20 | ENST00000409189.7 | c.179A>G | p.Asn60Ser | missense_variant | 2/4 | 1 | ENSP00000386273 | A1 | ||
CCL20 | ENST00000473642.1 | n.191A>G | non_coding_transcript_exon_variant | 1/3 | 2 | |||||
CCL20 | ENST00000489160.1 | n.248A>G | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000114 AC: 28AN: 246368Hom.: 0 AF XY: 0.000135 AC XY: 18AN XY: 133190
GnomAD4 exome AF: 0.000101 AC: 142AN: 1399570Hom.: 3 Cov.: 22 AF XY: 0.000111 AC XY: 78AN XY: 699854
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.182A>G (p.N61S) alteration is located in exon 2 (coding exon 2) of the CCL20 gene. This alteration results from a A to G substitution at nucleotide position 182, causing the asparagine (N) at amino acid position 61 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at